EVOKE
发表于 2025-3-21 18:44:52
书目名称Dose Finding and Beyond in Biopharmaceutical Development影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0284821<br><br> <br><br>书目名称Dose Finding and Beyond in Biopharmaceutical Development影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0284821<br><br> <br><br>书目名称Dose Finding and Beyond in Biopharmaceutical Development网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0284821<br><br> <br><br>书目名称Dose Finding and Beyond in Biopharmaceutical Development网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0284821<br><br> <br><br>书目名称Dose Finding and Beyond in Biopharmaceutical Development被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0284821<br><br> <br><br>书目名称Dose Finding and Beyond in Biopharmaceutical Development被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0284821<br><br> <br><br>书目名称Dose Finding and Beyond in Biopharmaceutical Development年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0284821<br><br> <br><br>书目名称Dose Finding and Beyond in Biopharmaceutical Development年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0284821<br><br> <br><br>书目名称Dose Finding and Beyond in Biopharmaceutical Development读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0284821<br><br> <br><br>书目名称Dose Finding and Beyond in Biopharmaceutical Development读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0284821<br><br> <br><br>
没有贫穷
发表于 2025-3-21 23:38:18
http://reply.papertrans.cn/29/2849/284821/284821_2.png
Demulcent
发表于 2025-3-22 04:20:17
http://reply.papertrans.cn/29/2849/284821/284821_3.png
手铐
发表于 2025-3-22 07:35:41
http://reply.papertrans.cn/29/2849/284821/284821_4.png
nominal
发表于 2025-3-22 08:54:56
http://reply.papertrans.cn/29/2849/284821/284821_5.png
Adrenaline
发表于 2025-3-22 16:27:36
https://doi.org/10.1007/978-3-642-92507-8luding leukemia 2023, kidney cancer, and melanoma (Siegel, CA Cancer J Clin 73(1):17–48, 2023). The development of targeted therapies, in particular, has dramatically altered the therapeutic landscape and improved outcomes for patients. Despite the seismic changes that have occurred in the field, so
Adrenaline
发表于 2025-3-22 18:05:17
dbreaking initiative had fundamentally changed the oncology dose-finding paradigm: discouraging outdated conventions since the era of cytotoxic agents (identifying the maximum tolerated dose, MTD), and embracing new practices of identifying the optimal dosage among multiple doses based on totality o
Fantasy
发表于 2025-3-22 22:08:46
Bits, Bytes, Words and Numbers,e treatments, oncology trials need to start human research at a lower dose level and then move up and down through some dose levels in a process called dose finding that helps determine a safe dose level. The toxicity of these oncology drugs is always assumed to increase with dose. However, unlike i
IOTA
发表于 2025-3-23 03:41:01
http://reply.papertrans.cn/29/2849/284821/284821_9.png
glucagon
发表于 2025-3-23 06:27:12
http://reply.papertrans.cn/29/2849/284821/284821_10.png